7V7

N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide

Find entries where: 7V7

is present as a standalone ligand in 6 entries

Find related ligands:

Chemical Component Summary
Name	N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Identifiers	~{N}-phenyl-~{N}-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Formula	C₂₂ H₂₈ N₂ O
Molecular Weight	336.471
Type	NON-POLYMER
Isomeric SMILES	CCC(=O)N(c1ccccc1)C2CCN(CC2)CCc3ccccc3
InChI	InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3
InChIKey	PJMPHNIQZUBGLI-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	53
Chiral Atom Count	0
Bond Count	55
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB00813
Name	Fentanyl
Groups	vet_approved approved investigational illicit
Description	Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia.[A179542] Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia.[Label,L6598,L6601,L6604,L6607,L922,L6610,L6613] Fentanyl is related to other opioids like [morphine] and [oxycodone]. Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin.[A179542] In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths).[L6748] Opioid overdoses kill an average of 11 Canadians daily.[L6751] Fentanyl was FDA approved in 1968.[Label,L6598,L6601,L6604,L6607,L922,L6610,L6613]
Synonyms	N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide N-phenethyl-4-(N-propionylanilino)piperidine N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide Fentanil Fentanyl citrate Fentanyl Phentanyl Fentanyl hydrochloride 1-Phenethyl-4-(N-phenylpropionamido)piperidine Fentanylum Fentanilo N-(1-phenethyl-4-piperidyl)propionanilide Fentanila Fentanyl CII N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide 1-phenethyl-4-N-propionylanilinopiperidine N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
Brand Names	Fentanyl Transdermal Abstral fentanyl Pat-fentanyl Mat Fentanyl Citrate Injection U.S.P.-liq IV Im Epd Fentanyl Citrate, Bupivacaine HCl Innovar Inj Sublimaze Fentanyl Citrate Injection Duragesic Fentanyl Transdermal System 25 Duragesic 12 Co Fentanyl Fentanyl Transdermal System 75 Fentanyl Citrate Injection USP 50mcg/ml Teva-fentanyl Fentanyl Transdermal System 100 Ran-fentanyl Transdermal System Fentanyl Buccal FENTANYL TRANSDERMAL system Sublimaze Inj 50mcg/ml Fentanyl System PMS-fentanyl Mtx Fentanyl Citrate Injection USP Fentanyl Citrate Injection, USP Abstral Duragesic 25 Fentanyl Instanyl Subsys Fentanyl - NOVAPLUS Mylan-fentanyl Matrix Patch Fentanyl Injection BP Fentanyl Transdermal System Apo-fentanyl Matrix Duragesic 50 Pecfent Fentanyl Citrate Injection Sdz Fentanyl transdermal system Duragesic 75 Fentanyl system Onsolis Ran-fentanyl Matrix Patch Fentanyl Transdermal System 50 Effentora Ionsys DURAGESIC (fentanyl system) Fentora Fentanyl Patch Lazanda Duragesic 100 Sandoz Fentanyl Patch Actiq Transmucosal Fentanyl Citrate Fentanyl Citrate
Indication	Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia.[Label] These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia.[Label] Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.[Label] Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.[L6598,L6601,L6604,L6607,L922,L6610]
Categories	Adjuvants Adjuvants, Anesthesia Agents that produce hypertension Agents that reduce seizure threshold Analgesics Anesthetics Anesthetics, General Anesthetics, Intravenous Antidepressive Agents Bradycardia-Causing Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Fentanyl and fentanyl analogues High-risk opioids Narcotics Nervous System Neuraxial Anesthetics Opiate Agonists Opioid Agonist Opioid Anesthetics Opioids Opioids, Anilidopiperidine P-glycoprotein inhibitors Peripheral Nervous System Agents Phenylpiperidine opioids Piperidines Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators
ATC-Code	N01AH01 N02AB03 N01AH51
CAS number	437-38-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Mu-type opioid receptor	MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRT...	unknown	agonist
Delta-type opioid receptor	MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAI...	unknown	agonist
Kappa-type opioid receptor	MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLE...	unknown	agonist
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 3A7	MDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNA...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
alpha1-acid glycoprotein	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	binder
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682